Quantamental Technologies’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-12,386
Closed -$454K 659
2022
Q4
$454K Buy
+12,386
New +$490K 0.21% 181
2019
Q4
Sell
-3,500
Closed -$186K 1467
2019
Q3
$186K Buy
+3,500
New +$180K 0.06% 526
2019
Q2
Sell
-155
Closed -$8K 1901
2019
Q1
$8K Sell
155
-6,500
-98% -$315K ﹤0.01% 1267
2018
Q4
$262K Buy
+6,655
New +$309K 0.16% 196

Other funds holding SYNH

Quantamental Technologies's SYNH Position: Q1 2023 in Review

Quantamental Technologies sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 12,386 shares — an estimated $454K sold.

Quantamental Technologies first reported a position in SYNH in Q4 2018 and held it in 4 quarters. The position peaked at $454K in Q4 2022. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

  • Quantamental Technologies reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Quantamental Technologies sold 12,386 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $454K.
  • Quantamental Technologies first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2018 and held it in 4 quarters.
  • Quantamental Technologies's Syneos Health, Inc. Class A Common Stock position peaked at $454K in Q4 2022.
  • 305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on Quantamental Technologies's 13F filing for Q1 2023, filed 15 May 2023.